JW PHARMACEUTICAL
001060 | KO
Overview
Corporate Details
- ISIN(s):
- KR7001060003
- LEI:
- Country:
- South Korea
- Address:
- 경기도 과천시 과천대로7길 38 -, 과천시
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
No description available.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
You have of free filing views remaining.
Upgrade for unlimited access.
Bulk Actions:
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2025-08-14 00:00 |
Interim / Quarterly Report
반기보고서 (2025.06)
|
Korean | 3.1 MB | ||
| 2025-07-31 00:00 |
Earnings Release
영업(잠정)실적(공정공시)
|
Korean | 13.3 KB | ||
| 2025-07-31 00:00 |
Governance Information
공정거래자율준수프로그램운영현황(안내공시)
|
Korean | 30.7 KB | ||
| 2025-07-02 00:00 |
Major Shareholding Notification
주식등의대량보유상황보고서(약식)
|
Korean | 62.4 KB | ||
| 2025-07-01 00:00 |
Major Shareholding Notification
주식등의대량보유상황보고서(일반)
|
Korean | 103.8 KB | ||
| 2025-06-25 00:00 |
Transaction in Own Shares
자기주식취득결과보고서
|
Korean | 62.4 KB | ||
| 2025-06-13 00:00 |
Legal Proceedings Report
벌금등의부과
|
Korean | 5.9 KB | ||
| 2025-05-30 00:00 |
Governance Information
기업지배구조보고서공시
|
Korean | 928.8 KB | ||
| 2025-05-15 00:00 |
Quarterly Report
분기보고서 (2025.03)
|
Korean | 2.4 MB | ||
| 2025-05-07 00:00 |
Earnings Release
영업(잠정)실적(공정공시)
|
Korean | 13.3 KB | ||
| 2025-04-21 00:00 |
Management Reports
기업가치제고계획(자율공시) (2025년)
|
Korean | 7.5 KB | ||
| 2025-04-04 00:00 |
Major Shareholding Notification
최대주주등소유주식변동신고서
|
Korean | 40.6 KB | ||
| 2025-04-04 00:00 |
Major Shareholding Notification
주식등의대량보유상황보고서(일반)
|
Korean | 109.2 KB | ||
| 2025-03-26 00:00 |
AGM Information
정기주주총회결과
|
Korean | 29.5 KB | ||
| 2025-03-26 00:00 |
Board/Management Information
사외이사의선임ㆍ해임또는중도퇴임에관한신고
|
Korean | 10.8 KB |
Automate Your Workflow. Get a real-time feed of all JW PHARMACEUTICAL filings delivered via API.
Market Data
Market Data Not Available
Last Price
Change / %
Market Cap
N/A
Volume
Day High
Day Low
52W High
52W Low
Financials & KPIs
No data available
Unlock Full Financials for JW PHARMACEUTICAL
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for JW PHARMACEUTICAL via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
Company
Country
Ticker
View
Developing targeted immunotherapies, including a vaccine, for Alzheimer's disease.
Sweden
ALZ
Sweden
ALZ
Develops prescription therapies like Vascepa® to reduce cardiovascular risk for patients.
United States of America
AMRN
United States of America
AMRN
Biotech pioneer developing innovative human therapeutics for the world's toughest diseases.
United States of America
AMGN
United States of America
AMGN
South Korea
092040
Develops advanced therapies for rare lysosomal storage disorders.
United States of America
FOLD
United States of America
FOLD
Manufactures high-purity chiral amino acids & APIs for pharma, chemical, and food industries.
South Korea
074430
South Korea
074430
Develops & commercializes essential medicines: generics, injectables & specialty drugs.
United States of America
AMRX
United States of America
AMRX
Develops and manufactures complex injectable, intranasal, and inhalation pharmaceutical products.
United States of America
AMPH
United States of America
AMPH
Developing novel therapies for neurodegenerative diseases like ALS and Wolfram syndrome.
United States of America
AMLX
United States of America
AMLX
Developing novel small molecule drugs for infectious diseases and oncology using boron chemistry.
United States of America
ANTX
United States of America
ANTX